Development and Testing of a Mobile App to Scale Delivery of Cognitive-behavioral Therapy for Avoidant/Restrictive Food Intake Disorder
Massachusetts General Hospital
Summary
Avoidant/restrictive food intake disorder (ARFID) is a serious and impairing eating disorder - occurring in up to 4% of adults - for which most individuals do not have access to treatment. The proposed study aims to develop and test a mobile app to scale delivery of cognitive-behavioral therapy for ARFID. Knowledge gained will contribute to the development of a clinically accessible, scalable, inexpensive treatment for ARFID, a highly impairing disorder for which there are significant barriers to care access.
Eligibility
- Age range
- 18–55 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. Current avoidant/restrictive food intake disorder based on DSM-5 criteria 2. Must not have completed face-to-face CBT-AR at the Eating Disorders Clinical and Research Program at Massachusetts General Hospital 3. Ability to speak, write, and understand English 4. Residence in the United States 5. Access to an internet-connected smartphone device Exclusion Criteria: 1. Underweight status (i.e., BMI \< 18.5 kg/m2) 2. Complete lack of oral intake or dependence on supplemental feeding 3. Feeding or eating disorder other than ARFID 4. Any comorbid clinically significant dis…
Interventions
- BehavioralmCBT-AR
mCBT-AR is an 8-week virtual treatment for avoidant/restrictive food intake disorder delivered via mobile application
Location
- Massachusetts General HospitalBoston, Massachusetts